🇺🇸 FDA
Patent

US 10111859

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

granted A61KA61K31/404A61K31/41

Quick answer

US patent 10111859 (Methods and compositions associated with the granulocyte colony-stimulating factor receptor) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/404, A61K31/41, A61K31/4152, A61K31/4155